Improved analysis of in vivo drug combination experiments with a comprehensive statistical framework and web-tool

Area of Science:

• Oncology
• Pharmacology
• Biostatistics

Background:

• Cancer monotherapy often shows limited efficacy, necessitating combination drug approaches.
• Existing in vitro tools for drug synergy assessment lack comprehensive in vivo statistical analysis.
• There is a critical need for integrated methods to analyze preclinical in vivo drug combination experiments.

Purpose of the Study:

• To introduce SynergyLMM, a novel framework for modeling and designing in vivo drug combination studies.
• To provide robust statistical analysis for drug synergy and antagonism in preclinical settings.
• To enable optimization of study designs, including sample size and follow-up duration, for preclinical drug combination trials.

Main Methods:

• SynergyLMM offers a comprehensive modeling and design framework for evaluating drug combination effects.
• It accommodates complex experimental designs, including multi-drug combinations and longitudinal data.
• The framework includes statistical analysis for synergy/antagonism, model diagnostics, and power analysis.

Main Results:

• SynergyLMM supports the statistical analysis of both synergy and antagonism in longitudinal drug interaction studies.
• It provides tools for model diagnostics and statistical power analysis to optimize study design.
• The web-application is accessible to researchers without programming skills, demonstrating versatility across various experimental setups.

Conclusions:

• SynergyLMM addresses the gap in statistical analysis for in vivo drug combination experiments.
• It enhances the robustness, rigor, and consistency of preclinical drug combination research.
• The framework facilitates a more efficient and reliable transition of findings from preclinical studies to clinical applications.